Login / Signup

Assessment of end-of-treatment transition needs for pediatric cancer and hematopoietic stem cell transplant patients and their families.

Jeffrey S KarstJennifer A HoagSherilynn F ChanDebra J SchmidtLynnette J AndersonNicole E EnglebertEva C IglerKristin M Bingen
Published in: Pediatric blood & cancer (2018)
There are many essential components to end-of-treatment care that are not consistently provided to pediatric cancer patients and families. Formalized programs offering education and support should be provided by multidisciplinary teams prior to the end of active treatment.
Keyphrases
  • healthcare
  • public health
  • end stage renal disease
  • newly diagnosed
  • squamous cell carcinoma
  • combination therapy
  • chronic pain